Excel in a Demanding New Category
Both the promises and the challenges of biopharmaceuticals are enormous.
Tanvex BioPharma, Inc. is a modern pharmaceutical company in the clinical stage of commercial development. Planned by Dr. Allen Chao, formerly founder and CEO of Watson Pharmaceuticals, Tanvex BioPharma is making new biopharmaceutical products more accessible.
Check out the latest news about Tanvex BioPharma and developments in the biopharmaceutical industry.
- Oct. 17, 2021 Tanvex received marketing authorization from Health Canada
- Oct. 4, 2021 FDA Accepts TX05 BLA Filing
- Aug. 3, 2021 Tanvex submits TX05 BLA to FDA
- Jun. 20, 2021 Tanvex entering into service contract with OBI
- May. 21, 2021 FDA delayed inspection for TX01